{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:22:01Z","timestamp":1791836521346,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81672013"],"award-info":[{"award-number":["81672013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81471938"],"award-info":[{"award-number":["81471938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National S & T Major Project for Infectious Diseases","award":["2017ZX10302201"],"award-info":[{"award-number":["2017ZX10302201"]}]},{"name":"the National S & T Major Project for Infectious Diseases","award":["2012ZX10002-005"],"award-info":[{"award-number":["2012ZX10002-005"]}]},{"name":"Science Foundation of Beijing Ditan hospital Capital Medical University","award":["DTYM201604"],"award-info":[{"award-number":["DTYM201604"]}]}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jcv.2017.12.016","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T23:38:35Z","timestamp":1515195515000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-na\u00efve HBV-infected individuals"],"prefix":"10.1016","volume":"99-100","author":[{"given":"Hongxin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2017.12.016_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1473-3099(07)70264-5","article-title":"Therapeutic strategies in the management of patients with chronic hepatitis B virus infection","volume":"8","author":"Papatheodoridis","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2017.12.016_bib0010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2017.12.016_bib0015","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2017.12.016_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.21299","article-title":"Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients","volume":"44","author":"Laras","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","article-title":"HBV cure: why, how, when?","volume":"18","author":"Levrero","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0040","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.75.10.4832-4842.2001","article-title":"Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase","volume":"75","author":"Boyer","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jcv.2017.12.016_bib0050","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","article-title":"Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells","volume":"47","author":"Tuttleman","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2017.12.016_bib0060","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/JVI.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0065","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jcv.2017.12.016_bib0070","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2003.11.008","article-title":"Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis","volume":"40","author":"Brunetti","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis","volume":"41","author":"Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2017.12.016_bib0095","doi-asserted-by":"crossref","first-page":"e89046","DOI":"10.1371\/journal.pone.0089046","article-title":"Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2017.12.016_bib0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.20695","article-title":"Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B","volume":"41","author":"Chan","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Grimm","year":"2011","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jcv.2017.12.016_bib0110","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/liv.12807","article-title":"Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma","volume":"35","author":"Saitta","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jcv.2017.12.016_bib0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/bjc.1976.205","article-title":"Hepatitis B surface antigen produced by a human hepatoma cell line","volume":"34","author":"MacNab","year":"1976","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2017.12.016_bib0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/286535a0","article-title":"Integration of hepatitis B virus sequences and their expression in a human hepatoma cell","volume":"286","author":"Edman","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2017.12.016_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jcv.2017.12.016_bib0130","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0135","doi-asserted-by":"crossref","first-page":"e40363","DOI":"10.1371\/journal.pone.0040363","article-title":"Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2017.12.016_bib0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2016.10.034","article-title":"Reply to: serum HBV pgRNA as a clinical marker for cccDNA activity","volume":"66","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3851\/IMP2777","article-title":"On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy","volume":"20","author":"Huang","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jcv.2017.12.016_bib0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.27381","article-title":"Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors","volume":"61","author":"van B\u00f6mmel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jiv397","article-title":"Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos(t)ide analogues","volume":"213","author":"Jansen","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2017.12.016_bib0160","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00535-012-0737-2","article-title":"Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients","volume":"48","author":"Tsuge","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0165","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0170","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2017.12.016_bib0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of t cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat. Med."},{"issue":"67","key":"10.1016\/j.jcv.2017.12.016_bib0180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"2017","author":"Lampertico","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0185","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.7150\/thno.18114","article-title":"The gRNA-miRNA-gRNA ternary cassette combining CRISPR\/Cas9 with RNAi approach strongly inhibits hepatitis B virus replication","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jcv.2017.12.016_bib0190","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.jcv.2017.12.016_bib0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-2-82","article-title":"B virus: inactive carriers","volume":"2","author":"Sharma","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.jcv.2017.12.016_bib0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2016.09.028","article-title":"Serum HBV pgRNA as a clinical marker for cccDNA activity","volume":"66","author":"Giersch","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0205","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhep.2013.12.014","article-title":"The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma","volume":"60","author":"Li","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2017.12.016_bib0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000321450","article-title":"Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection","volume":"4","author":"Kim","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.jcv.2017.12.016_bib0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fgene.2013.00202","article-title":"Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs","volume":"4","author":"Zhang","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.jcv.2017.12.016_bib0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jcv.2017.12.016_bib0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41598-017-00111-0","article-title":"Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217303566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217303566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T04:25:28Z","timestamp":1603599928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653217303566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":46,"alternative-id":["S1386653217303566"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2017.12.016","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-na\u00efve HBV-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}